Gabriel Mora Osoria
Endocrinology, Diabetes & Metabolism · Hatillo, PRNPI 1780153197
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,892 and has fallen 63.1% since, to $1,069 in 2025.
Across 253 payments — averaging $34.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Boehringer Ingelheim$956
- Medtronic$663
- AstraZeneca$639
- Sanofi-aventis U.S. LLC$625
- Johnson & Johnson$555
- plus $4K from 20 others
What the payments were for
- Travel & lodging$661%
- Food & beverage$8,60399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 21 | $1,226 |
| Boehringer Ingelheim | 22 | $956 |
| Medtronic | 22 | $663 |
| AstraZeneca | 16 | $639 |
| Sanofi-aventis U.S. LLC | 8 | $625 |
| Johnson & Johnson | 11 | $555 |
| Bayer | 5 | $461 |
| Novartis | 17 | $379 |
| Eli Lilly Export S.A. Puerto Rico Branch | 15 | $358 |
| Abbott | 15 | $321 |
| Novo Nordisk | 15 | $318 |
| Dexcom, Inc. | 16 | $312 |
| Lilly USA, LLC | 4 | $269 |
| PBG Puerto Rico LLC | 13 | $255 |
| AbbVie | 11 | $247 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $228 |
| Bayer Puerto Rico Inc. | 11 | $192 |
| Corcept Therapeutics | 3 | $148 |
| Gilead | 1 | $125 |
| Ascendis Pharma Endocrinology Inc | 1 | $125 |
| Boston Scientific | 4 | $66 |
| Merck | 3 | $58 |
| Rhythm Pharmaceuticals, Inc. | 2 | $52 |
| Chiesi USA, Inc. | 3 | $46 |
| Kyowa Kirin, Inc. | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,669 in reported general payments places this provider in the 70th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 32 | $31,802 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 30 | $18,425 |
| Xigduo XrDapaglifloz Propaned/Metformin | 21 | $12,391 |
| SynthroidLevothyroxine Sodium | 36 | $2,046 |
| Atorvastatin Calcium | 50 | $398 |
| Irbesartan | 13 | $232 |
| Rosuvastatin Calcium | 21 | $161 |
| Ezetimibe | 11 | $129 |
| Metformin Hcl | 18 | $105 |
| Lisinopril | 19 | $63 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $269 | $31,80232 claims |
| Boehringer IngelheimTrijardy Xr | $956 | $18,42530 claims |
| AbbVieSynthroid | $247 | $2,04636 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in Hatillo
- Luis Hernandez VazquezHatillo$20K
- Nicolas Cruz DardizHatillo$6K
- Jose Garcia MateoPonce$945K
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Alex Gonzalez BossoloSan Juan$110K
- Michelle Mangual GarciaSan Juan$87K
- Meliza Martinez RodriguezSan Juan$80K
- Milliette Alvarado SantiagoRio Piedras$75K
- Altagracia Alcantara GonzalezBayamon$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.